Ixaka Company
Ixaka is a private cell and gene therapy company with a focus on the natural power of the body to cure disease.
Technology:
CAR-T therapy, Cell-based gene therapy, Neurological Disorders
Industry:
Gene Therapy, Private
Headquarters:
London, England, United Kingdom
Founded Date:
2015-01-01
Employees Number:
51-100
Investors Number:
2
Total Funding:
72659949
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021-01-19
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership